Puissance Cross-Border Opportunities III LLC
Related Filers (5)
Bellerophon Therapeutics, Inc. (6)
Wang Theodore T (3)
Puissance Capital Management LP (3)
Puissance Capital Management (GP) LLC (3)
Puissance Capital Fund (GP) LLC (3)
Show More ...
Other (1)
F-3
Thursday, 10/5/2017
Registration statement for specified transactions by certain foreign private issuers
Show More
Ownership (6)
SC 13D/A
Friday, 5/22/2020
Bellerophon Therapeutics, Inc.: Major Shareholders
4
Monday, 4/20/2020
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 1/29/2019
Bellerophon Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 4/16/2018
Bellerophon Therapeutics, Inc.: Major Shareholders
3
Thursday, 10/5/2017
Bellerophon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Wednesday, 10/4/2017
Major Shareholders
Show More
Prospectus (1)
RW
Tuesday, 8/14/2018
Registration Withdrawal Request
Show More